Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
AffiliationArtsen Zonder Grenzen, Médecins Sans Frontières-Holland, Yangon, Myanmar, Thailand.
MetadataShow full item record
AbstractIn Rakhine State, on the western border of Myanmar, the efficacy of chloroquine (CQ) and pyrimethamine/ sulfadoxine (PS), the current treatments for uncomplicated Plasmodium falciparum malaria in this area, was evaluated in an open comparative study of 289 patients, stratified prospectively into 3 age groups. Chloroquine treatment was associated with more rapid clinical recovery (P = 0.03), but the overall cure rates were worse than for PS treatment; failure to clear parasitaemia or recrudescence within 14 d occurred in 72% (102/141) of cases treated with CQ compared to 47% (69/148) of those who received PS (P < 0.0001, adjusted for age). Failure rates at day 28 increased to 82% (116/141) in the CQ group and 67% (99/148) in the PS group (P = 0.003). The risk of treatment failure was significantly higher in children under 15 years old than in adults for both CQ (relative risk [RR] = 2.6; 95% confidence interval [95% CI] 1.3-5.2) and PS (RR = 2.2; 95% CI 1.4-3.3). Mefloquine (15 mg base/kg) proved to be highly effective as a treatment for CQ and PS resistant P. falciparum; only 2 of 75 patients (3%) had early treatment failures (< or = day 7), and the overall failure rate by day 42 was 7%. There is a very high level of chloroquine and PS resistance in P.falciparum on the western border of Myanmar, but mefloquine was effective in the area.
- Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
- Authors: Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ
- Issue date: 2004 Nov
- Response of falciparum malaria to different antimalarials in Myanmar.
- Authors: Ejov MN, Tun T, Aung S, Sein K
- Issue date: 1999
- Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
- Authors: Mohapatra PK, Prakash A, Taison K, Negmu K, Gohain AC, Namchoom NS, Wange D, Bhattacharyya DR, Goswami BK, Borgohain BK, Mahanta J
- Issue date: 2005 May
- A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria.
- Authors: Müller O, van Hensbroek MB, Jaffar S, Drakeley C, Okorie C, Joof D, Pinder M, Greenwood B
- Issue date: 1996 Feb
- Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
- Authors: Ezedinachi EN, Ekanem OJ, Chukwuani CM, Meremikwu MM, Ojar EA, Alaribe AA, Umotong AB, Haller L
- Issue date: 1999 Jul